High Intensity Focused Ultrasound Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

International Sonablate HIFU Prostate Registry Officially Launched
The HEAT Registry, with more than 1,500 patients, begins enrollment of U.S. patients CHARLOTTE, N.C., April 11, 2017 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultraso... Devices, Urology SonaCare Medical, Sonablate, HIFU, HEAT Registry (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2017 Category: Pharmaceuticals Source Type: news

Theraclion touts 2-year Echopulse data from breast fibroadenoma study
Theraclion (EPA:ALTHE) this week released 2-year results from a trial of its Echopulse non-invasive ultrasound system for treating breast fibroadenoma. Study results were published in the March 2017 issue of the Journal of Therapeutic Ultrasound, the French company said. The 20 patient study examined the use of the Echopulse system, an ultrasound-guided high-intensity focused ultrasound device, in reducing the volume of 26 breast fibroadenomas, or benign tumors. Data indicated that mean BFA volume was reduced by 77.32% after a single procedure and 90.47% after 2 procedures at 2 years. No cases of re-growth of treated le...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Ultrasound Women's Health Theraclion Source Type: news

New method heats up ultrasonic approach to treating tumors
High-intensity focused ultrasound (HIFU) is a breakthrough therapeutic technique used to treat tumors. The principle of this noninvasive, targeted treatment is much like that of focusing sunlight through a lens, using an ultrasonic transducer like a convex lens to concentrate ultrasound into a small focal region. Researchers have now designed a transducer for potential application in HIFU that can generate a steady, standing-wave field with a subwavelength-scale focal region and extremely high ultrasound intensity. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 28, 2017 Category: Science Source Type: news

New method heats up ultrasonic approach to treating tumors
(American Institute of Physics) High-intensity focused ultrasound (HIFU) is a breakthrough therapeutic technique used to treat tumors. The principle of this noninvasive, targeted treatment is much like that of focusing sunlight through a lens, using an ultrasonic transducer like a convex lens to concentrate ultrasound into a small focal region. Researchers have now designed a transducer for potential application in HIFU that can generate a steady, standing-wave field with a subwavelength-scale focal region and extremely high ultrasound intensity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 28, 2017 Category: Cancer & Oncology Source Type: news

Hitting cancer with high-intensity ultrasound, immunotherapy
In a new study, researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 23, 2017 Category: Science Source Type: news

MRI-guided high-intensity focused ultrasound therapy for uterine fibroids has potential
(Institute for Quality and Efficiency in Health Care) IQWiG has attributed a potential for a benefit to a new treatment method according to § 137e SGB V. A testing study has been initiated. Numerous other assessments had no consequences. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2017 Category: Global & Universal Source Type: news

High-Intensity Focused Ultrasound for Focal Therapy High-Intensity Focused Ultrasound for Focal Therapy
Focal HIFU shows promise for the treatment of prostate cancer, but important questions remain.Current Opinion in Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2017 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

First patients treated in pivotal trial for Theraclion ’ s Echopulse device
Theraclion (EPA:ALTHE) said today that the 1st patients were treated in the U.S. pivotal clinical trial evaluating the safety and efficacy of the company’s Echopulse echotherapy device as a non-invasive treatment for breast fibroadenomas. The clinical trial is slated to enroll 100 patients, the France-based company said, at 4 sites across the U.S. and 1 site in Germany. Patients will receive a single high-intensity treatment with Echopulse. The study’s primary endpoint is a reduction of fibroadenoma volume, pain and anxiety. “High intensity focused ultrasound (HIFU) technology is exciting because it has ...
Source: Mass Device - February 9, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Imaging Oncology Wall Street Beat Theraclion Source Type: news

HIFU-Hemiablation for Treatment of Prostate Cancer? HIFU-Hemiablation for Treatment of Prostate Cancer?
Dr Gerald Chodak questions the value of the IDEAL study to evaluate HIFU-hemiablation as the primary treatment for prostate cancer.Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA clears next-gen Sonablate prostate device from SonaCare
SonaCare Medical said today that it won 510(k) approval from the FDA for the latest version of its high intensity focused ultrasound prostate tissue ablation device. The Sonablate device was the 1st of its kind to receive regulatory approval for the focused ablation of prostate tissue, according to SonaCare. The next-gen version features a tool to quantify changes in tissue composition following treatment. It also boasts an altered delivery sequence in combination with an automated planning system that can reduce the overall procedure time by 40%, the Charlotte, N.C.-based company reported. “We worked diligently with...
Source: Mass Device - January 11, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Ultrasound SonaCare Medical Source Type: news

SonaCare Medical Granted FDA Regulatory Clearance for Updated HIFU Prostate Tissue Ablation Device
CHARLOTTE, N.C., Jan. 11, 2017 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, reports receipt of 510(k) regulatory clearance to market its latest ... Devices, Urology, FDA SonaCare Medical, Sonablate, HIFU (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2017 Category: Pharmaceuticals Source Type: news

Celsion ’ s ThermoDox activated by ultrasound in pediatric cancer study
Celsion (NSDQ:CLSN) and Children’s National Health System are teaming up to tackle refractory solid tumors in pediatric patients using a heat-activated chemotherapy drug and noninvasive ultrasound. The Phase I clinical trial, which launched last November, is the 1st of its kind in the U.S. Lawrenceville, N.J.-based Celsion’s ThermoDox is a heat-activated liposomal doxorubicin. In combination with MRI, high-intensity focused ultrasound is used to direct sound wave energy and heat the tumor. When the liposomal chemotherapy drug comes into contact with the heated tumor, the liposome changes structure and releas...
Source: Mass Device - January 6, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pediatrics Celsion Children's National Health System Source Type: news

Parkinson's UK comments on the first non-invasive ultrasound that can help patients with tremors
Claire Bale, Head of Research Communications and Engagement at Parkinson's UK, comments on Imperial College Healthcare NHS trust using high-intensity, focused ultrasound waves for the first time in... (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - December 12, 2016 Category: Neurology Tags: Parkinson's Disease Source Type: news

New trial will assess MR-HIFU, chemo drug combo
The Children's National Health System in Washington, DC, and oncology drug...Read more on AuntMinnie.comRelated Reading: FDA OKs InSightec's MRgFUS tremor treatment device New HIFU center launches in Ohio SonaCare, Invivo team up for HIFU ablation tracking Prostate HIFU available for 1st time in U.S. SonaCare lands FDA nod for HIFU system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2016 Category: Radiology Source Type: news

Pricey New Treatment Roils Issues of How to Treat Prostate Cancer Pricey New Treatment Roils Issues of How to Treat Prostate Cancer
High-intensity focused ultrasound, often not covered by insurance, leads to discussions about which patients benefit in the real world.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 6, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news